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Abstract: 
In this article, the liquid metal GaInSn alloy (67% Ga, 20.5% In, and 12.5% Sn by volume) is 
proposed for the first time to repair the peripheral neurotmesis as connecting or functional recovery 
channel. Such material owns a group of unique merits in many aspects, such as favorable fluidity, 
super compliance, high electrical conductivity, which are rather beneficial for conducting the 
excited signal of nerve during the regeneration process in vivo. It was found that the measured 
electroneurographic signal from the transected bullfrog’s sciatic nerve reconnected by the liquid 
metal after the electrical stimulation was close to that from the intact sciatic nerve. The control 
experiments through replacement of GaInSn with the conventionally used Riger’s Solution revealed 
that Riger’s Solution could not be competitive with the liquid metal in the performance as 
functional recovery channel. In addition, through evaluation of the basic electrical property, the 
material GaInSn works more suitable for the conduction of the weak electroneurographic signal as 
its impedance was several orders lower than that of the well-known Riger’s Solution. Further, the 
visibility under the plain radiograph of such material revealed the high convenience in performing 
secondary surgery. This new generation nerve connecting material is expected to be important for 
the functional recovery during regeneration of the injured peripheral nerve and the optimization of 
neurosurgery in the near future. 
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1. Introduction 
In modern society, peripheral nerve injury is an increasing source of morbidity worldwide, 
which often results in restricted activity or life-long disability. 
[1]
 Despite the progress in the 
cognition on anatomy and pathophysiology of the peripheral nerve system, as well as innovations in 
microsurgical techniques and materials, the management of peripheral nerve injuries remains a big 
challenge so far.
 [2]
 The repair and regeneration of the peripheral neurotmesis caused by accidental 
trauma, disease, or surgical procedures has been found rather tough, which usually requires 
extremely complex surgical intervention, lengthy process of regeneration and may have certain 
probability of functional disability after regeneration.  
So far, various microsurgical treatments and materials have been investigated for optimal 
repairing and regeneration of the transected peripheral nerve. The method of direct suturing of the 
cut ends (nerve stumps) is commonly employed when the gap is no longer larger than 20mm, while 
if a significant nerve gap exists, the necessity of nerve graft, nerve transfers or tubulization 
techniques stand out. 
[3]
 Since the infection of the nerve stumps or the retraction due to their 
elasticity often increase the extent of the gap, the reconnection and regeneration of transected 
peripheral nerve with large defects turns out a core issue in neurosurgery. As the current gold 
standard, nerve autografting 
[4]
 becomes the most common way when the direct suturing is not 
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preferred. However, disadvantages of nerve autografting, such as the need for a secondary surgery, 
significant donor site morbidity and limited length of available graft resource make it a 
problematical method. In contrast to nerve autografting, nerve allografting makes it possible to 
bridge larger nerve defects, 
[5]
 but the requirement of systemic immunosuppression lasts for 18 
months. And during this time, patients are prone to opportunistic infections and tumor formation. 
[6]
 
The reconstruction with the method of nerve transfers 
[7]
 depends on the donor nerve close to the 
transected peripheral nerve. In comparison with auotologous nerve grafts, the demand for long 
nerve grafts by way of nerve transfers is avoided, while it may result in disfunction of the donor 
nerve muscle. In order to find out an alternative method, various natural and synthetic biomaterials 
have been investigated as nerve conduits in experimental and clinical conditions. 
[8]
 As only several 
commercially available synthetic nerve conduits have been approved by the U.S. FDA, 
[9]
 and the 
therapeutic effect of such conduits appears only feasible for the short gap case, both the materials 
and fabrication technique require tremendous efforts in tubular implants and scaffolds.  
Apart from the methods of bridging the transected peripheral nerve, acceleration of peripheral 
nerve regeneration has been extensively researched. 
[10]
 Growth factors, support cells or insoluble 
extracellular matrices have been demonstrated to promote peripheral nerve regeneration. Although 
various strategies of microsurgical treatments and materials for peripheral neurotmesis have been 
enormously improved over the past decades, the outcome in repairing the peripheral neurotmesis 
remains unsatisfactory as the full functional recovery is seldom achieved. 
[11]
 In addition, peripheral 
nerve regeneration is a lengthy process. Taken axonal regeneration as an example, the speed of 
regeneration and restoration approximates 1 mm/d. 
[12]
 Years may be needed for reinnervation 
because of the large nerve defect. Over this period, degeneration will occur, and the denervated end 
organs undergo histologic changes that are consistent with muscle atrophy and infiltration of fibrous 
tissue. Consequently, target muscle atrophy becomes irreversible, which may lead to the impaired 
physiological function, resulting in long-term disabilities. 
[13]
 Therefore, taking the functional 
recovery into consideration during the regeneration is of great significance for patients. 
Recently, the eutectic GaInSn alloy has been found to own several intrinsic properties, which 
may be advantageous as peripheral nerve functional recovery channel during the regeneration of 
transected peripheral nerve. With a broad temperature range of liquid phase, the room temperature 
liquid metal GaInSn alloy (67% Ga, 20.5% In, and 12.5% Sn by volume) may make it more 
convenient in fabrication, encapsulation and surgical operation. 
[14]
 Theoretically, such liquid metal 
is zero stiffness and almost infinite stretchability due to its fluidity, 
[15]
 which is super compliant in 
vivo. The electrical conductivity of such material is 3.1*10
6
 Sm
-1
, which is several orders higher 
than those of non-metallic materials and in contrast with many other metallic materials commonly 
used in electric transmission.
[16]
 Therefore, it may minimize ohm loss and conduct weak 
electroneurographic signal maximally. The chemical compatibility, tunable wettability, and the 
ability to be directly printed on a wide variety of materials 
[17] 
such as polymers, glass, and metals 
make it cooperate with nerve conduits harmoniously. 
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In the present work, the liquid metal GaInSn was proposed for the first time to treat peripheral 
neurotmesis as functional recovery channel during the regeneration of the nerve. The animal study 
has been approved by the Ethics Committee of Tsinghua University, Beijing, China under contract 
[SYXK (Jing) 2009-0022]. As the first trial in this direction, the liquid metal used in the 
experiments was a kind of eutectic of Ga, In and Sn alloy with a volume proportion of 67%, 20.5% 
and 12.5%, respectively. The detailed synthesis procedures were outlined in former study. 
[18]
 We 
demonstrated the feasibility and advantages of such material through the reconnection of the 
transected bullfrog sciatic nerve in vitro. To evaluate the basic electrical property of GaInSn alloy, 
its resistivity and impedance were measured. Besides, the visibility under the plain radiograph was 
investigated. Different from the conventional neurosurgery, the innovative material employed in the 
repair of peripheral nerve is expected to efficiently conduct electroneurographic signal during the 
regeneration, and avoid degeneration or even target muscle atrophy. 
 
2. Materials and Methods  
The experimental subject was established as the sciatic nerve with gastrocnemius from 
bullfrogs under the consideration that it has been serving as one of the most typical specimens in the 
neurological test and easily available. Ten living bullfrogs were bought from the local market. The 
gastrocnemius with sciatic nerve was extracted with the double pithing method. The Riger’s 
Solution was prepared and applied to infiltrate the sciatic nerve and gastrocnemius in order to keep 
them active. After preparation of the experimental specimen, the intact sciatic nerve with 
gastrocnemius was infiltrated in the Riger’s Solution for twenty minutes. Since the 
electrophysiological stimulation is one of the dispensable methods in neuroscience research to 
induce synaptic plasticity and to probe synaptic function, 
[19] 
the voltage signal was employed to 
stimulate the proximal nerve. 
The experimental system to measure the electroneurographic signal was shown in Figure 1. 
Two glass dishes filled up with Riger’s Solution were used to contain the proximal sciatic nerve and 
gastrocnemius with distal sciatic nerve, and the glass slide was applied to position the nerve and 
isolate Riger’s Solution. Two methods to encapsulate the liquid metal or Riger’s Solution were 
shown in Figure 1 (b). One was that a piece of transparent plastic with a rectangular groove used 
for loading liquid metal or Riger’s Solution to reconnect the transected sciatic nerve was placed on 
the glass slide. The size of the groove was only 10mm*1mm*0.5mm, small enough to reduce the 
dosage of the liquid metal. Another was that the liquid metal or Riger’s Solution was filled in a 
glass capillary pipette with the length of 3cm and diameter of 0.5mm. The digital signal generator 
(Agilent 33210A, Agilent Technologies, U.S.A.) has been used to produce the electric-stimuli 
signal (Wave form: square-wave, Voltage amplitude: 0.2V, Frequency: 0.5Hz, Duty cycle: 20%). 
The data acquisition device (Agilent 34970A, Agilent Technologies, U.S.A.) with the resolution of 
0.001mV was employed to measure the electroneurographic signal after the simulation. The 
electroneurographic signal was displayed and collected by a computer. With the simulation of the 
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sciatic nerve, the innervated gastrocnemius became contracted. In order to record the dynamic 
behavior of the nerve subject to stimulation, the high-speed camera Canon XF305 was adopted.  
  
 
Figure 1. The experimental diagram for the overall system. (a) The experimental setup of 
measuring the electroneurographic signals. (b) The schematic diagram of the transected sciatic 
nerve reconnected by liquid metal and Riger’s Solution, respectively. To view it clearly, a little red 
ink was added into the Riger’s Solution. 
 
The negative terminals of both digital signal generator and data acquisition device were linked 
with the glass dish containing the distal nerve with gastrocnemius together. The positive terminal of 
the stimulation signal was loaded on the proximal nerve, while the positive terminal of the data 
acquisition device was put on the distal nerve, about 2cm away from the stimulation signal, as 
shown in Figure 1 (a). Before the sciatic nerve was transected, the electroneurographic signal of the 
intact nerve after stimulation was collected by the data acquisition device. The behavior of the 
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gastrocnemius was recorded by the high-speed camera simultaneously. Then the nerve was 
transected totally by ophthalmic scissors. In order to test the performance of functional reconnection, 
the transected nerve was reconnected by the liquid metal or Riger’s Solution and the 
electroneurographic signal as well as dynamic contraction after the same stimulation was recorded.  
In order to compare the electrical properties of the liquid metal GaInSn with the Riger’s 
Solution and characterize the electrical property quantitatively, the micro-ohmmeter (Agilent 
34420A, Agilent Technologies, U.S.A.) was employed. The resistance of the liquid metal or Riger’s 
Solution encapsulated in a glass capillary pipette with the length of 10cm and diameter of 0.5mm 
was measured under the direct voltage. Besides, the SRS Model SR780 2-Channel Network Signal 
Analyzer was adopted to measure the impedance of the liquid metal or Riger’ Solution encapsulated 
in a plastic tube with the length of 40cm and diameter of 1mm from 1Hz to 1kHz, and each group 
was measured five times to obtain the average results.  
It is expected the liquid metal could cooperate with biodegradable nerve conduits during the 
regeneration. Therefore, after the regeneration, if it is no longer necessary for keeping the liquid 
metal, the simple secondary surgery may be required. The visibility under the plain radiographs and 
fluidity could make it convenient to suck up the liquid metal via a micro-syringe. To investigate the 
visibility under the plain radiographs, the liquid metal was injected into the bullfrog’s leg where it 
was close to the sciatic nerve, and then the plain radiograph was acquired by X-ray under the 
dosage of 100V and 1mAs. After that, the liquid metal was sucked up by a micro-syringe, and the 
plain radiograph was acquired once again. 
 
3. Results and Discussion 
3.1. The electroneurographic signal 
A carefully selected electric-stimuli signal (Wave form: square-wave, Voltage amplitude: 0.2V, 
Frequency: 0.5Hz, Duty cycle: 20%) was applied to stimulate the proximal nerve. As the electric-
stimuli signal could excite the nerve, the measured waveform of electroneurographic signal on the 
intact nerve was not the same as the original electric-stimuli signal, which contained a positive 
phase wave and a negative phase wave during every periodicity, as shown in Figure 2 (a) and (b). 
The waveform was basically synchronized with the electric-stimuli signal and similar to the 
electric-stimuli signal in some degree. After the sciatic nerve was transected and reconnected 
through the selected liquid metal or Riger’s Solution, the electroneurographic signal on the distal 
nerve was collected (Figure 2 (a) and (b)). Though the electroneurographic signal from the 
transected sciatic nerve was virtually similar to that from the intact sciatic nerve, they were subtly 
different at the strategic locations. In Figure 2 (b), the difference was quite obvious, mainly at the 
peaks and the troughs. The statistics of the amplitudes of the electroneurographic signals and the 
changes at the peaks and troughs were shown in Figure 2 (c). The changes of the voltage on the 
transected distal nerve reconnected by the liquid metal were more coincided with that reconnected 
by Riger’s Solution. In addition, the same performance was obtained when the liquid metal or 
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Riger’s Solution was encapsulated in a glass capillary pipette with the length of 3cm and diameter 
of 0.5mm, respectively. By stimulating the intact sciatic nerve or reconnecting the transected sciatic 
nerve via liquid metal or Riger’s Solution, the gastrocnemius innervated by the sciatic nerve was 
contracted (see supplementary materials). 
 
 
Figure 2. The electroneurographic signal. (a) The electric-stimuli signal and the excitement signal 
from the intact nerve, the transected nerve reconnected by GaInSn or Riger’s Solution with the 
volume of 10mm*1mm*0.5mm, respectively. (b) Amplified detail of partial view (a). (c) The 
comparison of voltage changes after electrical stimulation.  
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As the sciatic nerve is composed by various kinds of nerve fibers, the recorded 
electroneurographic signals were compound nerve action potentials. In the neural electrophysiology, 
after the nerve receives effective stimulus, the action potentials could be generated. The action 
potentials on the nerve trunk were the compound action potentials from a number of nerve fibers. 
Thus, the characteristic of the action potentials on the nerve trunk was different from that on the 
single nerve fiber: the waveform was biphasic, which contained a positive phase and a negative 
phase. As seen in Figure 2, if removing the ΔV1 and ΔV2, the rest of the electroneurographic signals 
might mainly reflect the electric leakage by Riger’s Solution, which was inevitable since the 
existence of the Riger’s Solution was necessary to avoid the neurological impairment during the 
measurement. The real part that could denote the compound nerve action potentials was ΔV1 and 
ΔV2. The absolute value ΔV2 was larger than ΔV1, as shown in Figure 2 (c), mainly because the 
electric leakage might cover up the positive phase. The electric leakage was more obvious when the 
transected sciatic nerve was reconnected through the Riger’s Solution due to complete contact with 
the extracellular matrix. The applied liquid metal GaInSn is insoluble. Therefore, when the liquid 
metal was encapsulated in the nerve conduits, it could stay in the conduits and perform the 
conduction function of the electroneurographic signals stably.  
 
3.2. The comparison of physical properties 
The resistance of the used liquid metal and Riger’s Solution was 0.0224 Ω, 0.443787 MΩ, 
respectively (measured at room temperature 20
 o
C in a glass capillary pipette with the length of 
10mm and diameter of 0.5mm under direct current). Accordingly, the calculated resistivity of the 
liquid metal used and Riger’s Solution was 4.396*10-8Ω m and 0.8709Ω m, respectively, as shown 
in Table 1. The resistivity of the Riger’s Solution was several orders higher than the liquid metal 
GaInSn, which might result in the attenuation of electroneurographic signals. Hence, Riger’s 
Solution was not suitable for conducting the weak electroneurographic signals. The melting point of 
the liquid metal was 10.5 
o
C, which indicated that it remained in the liquid phase over the body 
temperature (37 
o
C).  
Table 1. Comparison of physical properties of GaInSn with Riger’s Solution 
 Density (kg m
-3
) Melting point (
o
C) Resistivity (Ω m) 
GaInSn 6360 10.5 4.396*10
-8
 
Riger’s Solution 1009 <4 0.8709 
 
From the view of impedance, both the resistance and the reactance of the applied GaInSn alloy 
were several orders lower than that of Riger’s Solution, as shown in Figure 3. Since the frequencies 
of most electroneurographic signals are below 10 kHz, the influence of the GaInSn reactance can be 
ignorable and hence the resistance remains the major determinant of the impedance. In addition, the 
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resistance of the GaInSn alloy was relatively stable from 1 Hz to 10 kHz. While for Riger’s 
Solution, the resistance and reactance were highly affected by frequency, which indicated that 
Riger’s Solution was not stable if it was applied for conducting dynamic signals. 
Furthermore, the viscosity of the applied GaInSn is 2.98*10
−7
 m
2
/s, 
[15]
 which elucidated that 
such material was super compliant in body and would not influence the mechanical properties of the 
nerve conduits. In general, the basic physical properties indicated that the GaInSn owns unique 
advantages for conducting electroneurographic signals in vivo. 
 
 
Figure 3. The impedance of the applied liquid metal GaInSn alloy and Riger’s Solution 
encapsulated in a plastic tube with length of 40cm and diameter of 1 mm. (a) The resistance and 
reactance curve of the liquid metal. (b) The resistance and reactance curve of Riger’s Solution. 
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3.3. The visibility under plain radiograph 
Under the plain radiograph, such material showed favorable visibility, as shown in Figure 4 (b). 
The liquid metal is close to the femur, as well as the sciatic nerve (seen in Figure 4 (a) and (b)). If 
liquid metal cooperates with the biodegradable nerve conduits, the visibility may contribute to the 
surgical navigation. Under the guidance of the plain radiograph, the liquid metal can be sucked up 
by a micro-syringe when the regeneration completed, and the complex secondary surgery is thus 
avoided.  
 
(a) 
 
 
(b)                                       (c) 
Figure 4. The pictures of bullfrog’s lower body. (a) The photograph of bullfrog’s lower body after 
injecting GaInSn alloy. (b) The plain radiograph of bullfrog’s lower body after injecting GaInSn 
alloy. (c) The plain radiograph of bullfrog’s lower body after sucking up GaInSn alloy with a micro-
syringe. 
 
It is necessary to note that the reason to choose Riger’s Solution as the control group is that it 
matches well with biological tissue without causing any safety problem. Though favorable 
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compatibility and safety it owns, Riger’s Solution is not suitable as the functional recovery channel 
due to its high resistivity and assimilation with the tissue. In contrast to Riger’s Solution, the 
applied liquid metal is insoluble and not absorbed. Concerns may be mentioned about the safety of 
the liquid metal in body. Fortunately, GaInSn is a chemically benign metal alloy.
 [20]
 Though the 
accurate electrochemical corrosion of such material needs further study, the main ingredient gallium 
has already been applied in medicine in many aspects. 
[21]
   
 
 
Figure 5. Three kinds of nerve conduits to repair the injured peripheral nerve. (a) Nerve conduit 
with microchannels. (b) Nerve conduit with a shape of thin slice. (c) Nerve conduit with concentric 
tubes. 
 
The liquid metal GaInSn shows great virtues that no other conventional material possesses, and 
it is promising to achieve functional recovery during the regeneration if combining the nerve 
conduits with liquid metal. It is of great concern for patients to alleviate the sufferings from 
peripheral neurotmesis and reduce the risk of physiological function impairment or even long-term 
disabilities. The related fabrication and encapsulation may not be complex, as many fashioned 
nerve conduits can be employed with small changes. One of the tentative ideas is to take advantage 
of the conventional nerve conduits with microchannels, 
[22]
 and fill the peripheral thicker channels 
with the liquid metal, as shown in Figure 5 (a). The paracentral thinner microchannels are filled 
with materials like growth factors, Schwann cell or insoluble extracellular matrices to promote the 
regeneration. Another tentative idea is to fabricate the nerve conduits with concentric tubes, in 
which the internal cylinder is filled with porous support materials and substances to promote the 
regeneration, while the periphery is filled with the liquid metal to conduct the electroneurographic 
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signals, as shown in Figure 5 (c). Apart from peripheral neurotmesis, it is expected that 
neurological decline due to disease or accidental crash can be improved by wrapping a 
biocompatible slice coating with liquid metal to enhance the conduction of electroneurographic 
signals, as shown in Figure 5 (b). 
 
4. Conclusion 
In summary, this work performed the first ever experiment to demonstrate that liquid metal 
GaInSn alloy could efficiently reconnect the transected sciatic nerve in vitro and conduct the 
electroneurographic signals. The applied liquid metal GaInSn was presented as an alternative 
medium over existing ones and might play an important role of the functional recovery channel 
cooperating with nerve conduits during regeneration. The unique diverse favorable properties of the 
GaInSn guarantee it an advantageous material for future clinical practices. Besides, the applied 
liquid metal could represent with similar electrical properties of the nerve. It is expected that such 
kind of materials could open a promising way for nerve functional recovery during the regeneration 
process and reduce the probability of functional impairment. 
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